0001140361-18-007635.txt : 20180214 0001140361-18-007635.hdr.sgml : 20180214 20180214103429 ACCESSION NUMBER: 0001140361-18-007635 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180214 DATE AS OF CHANGE: 20180214 EFFECTIVENESS DATE: 20180214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athyrium Capital Management, LP CENTRAL INDEX KEY: 0001728001 IRS NUMBER: 263965190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18509 FILM NUMBER: 18608514 BUSINESS ADDRESS: STREET 1: 530 FIFTH AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-402-6925 MAIL ADDRESS: STREET 1: 530 FIFTH AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001728001 XXXXXXXX 12-31-2017 12-31-2017 Athyrium Capital Management, LP

530 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10036

13F HOLDINGS REPORT 028-18509 N Andrew Hyman 212-402-6925 /s/ Andrew Hyman New York NY 02-14-2018 0 6 169055 false INFORMATION TABLE 2 form13fInfoTable.xml AEGERION PHARMACEUTICALS INC NOTE 2.000% 8/1 00767EAB8 77523 95045000 PRN SOLE 0 0 95045000 PTC THERAPEUTICS INC NOTE 3.000% 8/1 69366JAB7 36690 45567000 PRN SOLE 0 0 46567000 SUCAMPO PHARMACEUTICALS INC NOTE 3.250%12/1 864909AA4 14670 12000000 PRN SOLE 0 0 12000000 VIVUS INC NOTE 4.500% 5/0 928551AB6 29716 46000000 PRN SOLE 0 0 46000000 VIVUS INC NOTE 4.500% 5/0 928551AB6 9044 14000000 PRN DFND 0 0 14000000 APOLLO ENDOSURGERY INC COM 03767D108 1412 252079 SH SOLE 252079 0 0